Plant natural products (PNPs) are specialized metabolites with diverse bioactivities. They
are extensively used in the pharmaceutical, cosmeceutical and food industries. PNPs are …

The chloroplast of Chlamydomonas reinhardtii and other microalgae represents an attractive
new platform for the synthesis of recombinant therapeutics using synthetic biology (synbio) …

Currently, most commercial recombinant technologies rely on host systems. However, each
host has their own benefits and drawbacks, depending on the target products. Prokaryote …

Microalgae are a diverse group of single-cell photosynthetic organisms that include
cyanobacteria and a wide range of eukaryotic algae. A number of microalgae contain high …

Photosynthetic microalgae harbor enormous potential as light-driven green-cell factories for
sustainable bio-production of a range of natural and heterologous products such as …

In recent years, there has been an increasing interest in the exploitation of microalgae in
industrial biotechnology. Potentially, these phototrophic eukaryotes could be used for the …

Pharmaceuticals and personal care products (PPCPs) are often found in aquatic
environments. Microalgae-based bioremediation is cost-effective and ecologically friendly …

Sustainable and economically viable support for an ever-increasing global population
requires a paradigm shift in agricultural productivity, including the application of …

Pharmaceuticals are of increasing environmental concern as they emerge and accumulate
in surface‐and groundwater systems around the world, endangering the overall health of …

With the rapid development of synthetic biology, various kinds of microbial cell factories
(MCFs) have been successfully constructed to produce high-value-added compounds …